Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
BEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and ...
News-Medical.Net on MSN
Five-year project seeks new weapons against drug-resistant bacteria
Lethal lettuce in Missouri. Murderous onions in Colorado. To biochemists at the University of Oklahoma, these aren't just ...
Animal tests show promise to target invasive strain of E. coli but approval for use in humans is still years away ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
The India Gentamycin market is driven by rising bacterial infections and antimicrobial resistance, supported by government ...
Ashtabula Area City School District sued Liberty Mutual Fire Insurance Company in federal court this month, alleging the ...
DENVER, CO / ACCESS Newswire / November 4, 2025 / ForCast Orthopedics, a development-stage company focused on modernizing care for complex orthopedic infections, today announced that the US Food and ...
Half of the Staphylococcus epidermidis isolates found in raw milk from dairy cattle and sheep were multidrug resistant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback